Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eydenzelt, Celltrion’s biosimilar referencing Eylea, approved in Canada
2
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
3
The Art and Science of Presbyopia Correction: Navigating the IOL Patient Journey
4
Survey finds 3 in 4 Americans battle weekly dry eye symptoms
5
.png "Optometry Times"){kind=logo}
